Long-term trends in disease burden of esophageal cancer in China and the forecast until 2050
The projected number of cases and deaths from esophageal cancer in China will increase significantly by 2050, with corresponding increases in age‑standardized prevalence and mortality rates for the total population and males.
Esophageal cancer (EC) is one of the most common malignant tumors in China, with the number of new cases and deaths accounting for about half of the global total, imposing a heavy burden of disease.
Emerging trends predict a substantial rise in esophageal cancer burden in China, underscoring the need for targeted prevention and health‑policy interventions.
Bizonyítékszint: Feltételezés / hírjelzés. Nincs önálló tudományos bizonyíték.
Kapcsolódó jelek
- Advances in targeted therapy for esophageal cancer
- A review of esophageal cancer research: emerging trends, progress and perspectives
- An esophageal cancer clinical trial - ES3
- Case Report: Small bowel metastasis from esophageal squamous cell carcinoma: a case series and systematic review of clinical characteristics, tropism, and survival outcomes
- Current landscape of immunotherapy in esophageal cancer: a literature review